Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
73.17 ^USD	-0.12%		+8.67%	+26.57%

Apr. 26	Daiwa Adjusts Price Target on Boston Scientific to $81 From $73	MT
Apr. 26	Redburn Atlantic Adjusts Price Target on Boston Scientific to $79 From $75	MT

Boston Scientific Corporation Reports Intangible Asset Impairment Charges for the Third Quarter Ended September 30, 2021

October 27, 2021 at 06:45 am EDT

Boston Scientific Corporation reported intangible asset impairment charges for the third quarter ended September 30, 2021. Intangible asset impairment charges was $128 million against $219 million a year ago.

Latest news about Boston Scientific Corporation

Daiwa Adjusts Price Target on Boston Scientific to $81 From $73	Apr. 26	MT
Redburn Atlantic Adjusts Price Target on Boston Scientific to $79 From $75	Apr. 26	MT
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	Apr. 25	RE
UBS Raises Boston Scientific's Price Target to $90 From $74, Maintains Buy Rating	Apr. 25	MT
Oppenheimer Adjusts Boston Scientific's Price Target to $77 From $68	Apr. 25	MT
Bernstein Adjusts Boston Scientific Price Target to $86 From $75	Apr. 25	MT
Deutsche Bank Adjusts Price Target on Boston Scientific to $73 From $63	Apr. 25	MT
Baird Adjusts Price Target on Boston Scientific to $84 From $79	Apr. 25	MT
JPMorgan Adjusts Price Target on Boston Scientific to $82 From $72	Apr. 25	MT
Raymond James Adjusts Boston Scientific Price Target to $85 From $73	Apr. 25	MT
Wolfe Research Adjusts Boston Scientific Price Target to $81 From $72	Apr. 25	MT
CL King Adjusts Boston Scientific's Price Target to $82 From $72	Apr. 25	MT
Canaccord Genuity Adjusts Price Target on Boston Scientific to $83 From $81	Apr. 25	MT
Barclays Adjusts Boston Scientific's Price Target to $78 From $70	Apr. 25	MT
Wells Fargo Adjusts Price Target on Boston Scientific to $82 From $72	Apr. 25	MT
Truist Raises Price Target on Boston Scientific to $86 From $79, Keeps Buy Rating	Apr. 25	MT
Needham Adjusts Price Target on Boston Scientific to $82 From $71	Apr. 25	MT
RBC Capital Adjusts Price Target on Boston Scientific to $82 From $78	Apr. 25	MT
Mizuho Adjusts Price Target on Boston Scientific to $85 From $80	Apr. 25	MT
Health Care Down Amid Mixed Earnings -- Health Care Roundup	Apr. 24	DJ
Wall St edges lower as rising yields overshadow upbeat corporate results	Apr. 24	RE
BTIG Raises Boston Scientific's Price Target to $80 From $74	Apr. 24	MT
Morgan Stanley Raises Boston Scientific's Price Target to $79 From $72	Apr. 24	MT
Evercore ISI Raises Boston Scientific's Price Target to $78 From $72	Apr. 24	MT
Jefferies Raises Boston Scientific's Price Target to $82 From $74	Apr. 24	MT

Chart Boston Scientific Corporation

Duration

Period

More charts

Company Profile

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-02 - Annual General Meeting

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Boston Scientific Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

73.17 USD

Average target price

80.08 USD

Spread / Average Target

+9.44%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
THERMO FISHER SCIENTIFIC	+8.07%	218B
DANAHER CORPORATION	+6.59%	182B
INTUITIVE SURGICAL, INC.	+11.26%	132B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.98B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	47.59B
AGILENT TECHNOLOGIES, INC.	-0.93%	39.96B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.22B
RESMED, INC.	+26.76%	26.94B
ILLUMINA, INC.	-12.18%	19.28B

Other Advanced Medical Equipment & Technology